At CDMO Live Europe 2026, Jeff Mason, VP and Head of US Sales at Samsung Biologics, demonstrated a risk-based, parallel approach to dual-site technology transfer that delivered a first GMP batch at a second facility within 90 days of initiation.<a href="https://pharmasource.global/content/podcast/how-to-complete-a-dual-site-biologics-tech-transfer-in-90-days/" target="_blank" rel="noopener noreferer">Read the full article</a>.

CDMO Relationship Management Across the Americas: Why Culture Changes Everything

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing.

In each episode we'll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more besides.

Make sure to subscribe for your regular dose of pharma insight.